Showing results (1-10 of 296) with videos related to
Sort By:
Pageof 30
Expert Opinion on Investigational Drugs|June 4, 2004
Recent advances in natriuretic peptides in congestive heart failureGuido Boerrigter, John C BurnettCardiovascular Drug Reviews|April 21, 2007
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular diseaseGuido Boerrigter, John C BurnettCurrent Heart Failure Reports|July 23, 2005
Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implicationsGuido Boerrigter, John C BurnettHandbook of Experimental Pharmacology|December 18, 2008
Modulation of cGMP in heart failure: a new therapeutic paradigmGuido Boerrigter, Harald Lapp, John C BurnettThe Medical Clinics of North America|April 16, 2003
Revisiting salt and water retention: new diuretics, aquaretics, and natriureticsLisa C Costello-Boerrigter, Guido Boerrigter, John C BurnettExpert Opinion on Investigational Drugs|October 10, 2007
V2 receptor antagonism with tolvaptan in heart failureLisa C Costello-Boerrigter, Guido Boerrigter, John C BurnettHeart Failure Reviews|September 4, 2008
Pharmacology of vasopressin antagonistsLisa C Costello-Boerrigter, Guido Boerrigter, John C BurnettHeart Failure Clinics|July 28, 2009
Natriuretic peptides in the diagnosis and management of chronic heart failureGuido Boerrigter, Lisa C Costello-Boerrigter, John C BurnettCurrent Heart Failure Reports|September 4, 2008
Insights into natriuretic peptides in heart failure: an updateJosef Korinek, Guido Boerrigter, Selma F Mohammed, et al.Trends in Cardiovascular Medicine|March 19, 2013
GPCR biased ligands as novel heart failure therapeuticsJonathan D Violin, David G Soergel, Guido Boerrigter, et al.Pageof 30